Bayer's Stivarga Tablets Approved in Europe
August 30, 2013 at 06:05 AM EDT
Bayer HealthCare (OTC: BAYRY ) and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX ) announced today that the European Commission has approved Stivarga® (regorafenib) tablets for the treatment of adult patients with metastatic colorectal cancer (mCRC). In September 2012, Stivarga was approved by the U.S. Food and Drug Administration (FDA) for
